Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Innova CaptabNSE:INNOVACAP -0.65%46 Pretax Margin % is 11.32% as of Mar. 2026, which is 2% below its 10-year median of 11.53. GuruFocus rates NSE:INNOVACAP with a GF Score™ of 46/100. The stock has 6 warning signs investors should review. Among 961 Drug Manufacturers companies, Innova Captab ranks better than 61.71% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Innova Captab's Pre-Tax Income for the
three
months ended in Mar. 2026 was ₹507 Mil. Innova Captab's Revenue for the
three
months ended in Mar. 2026 was ₹4,478 Mil. Therefore, Innova Captab's pretax margin for the quarter that ended in Mar. 2026 was 11.32%.
The historical rank and industry rank for Innova Captab's Pretax Margin % or its related term are showing as below:
NSE:INNOVACAP'
s Pretax Margin % Range Over the Past 10 Years
Min: 9.73 Med: 11.53 Max: 13.85
Current: 11.55
NSE:INNOVACAP's Pretax Margin % is ranked better than 61.71% of 961
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs NSE:INNOVACAP: 11.55
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Innova Captab Pretax Margin % Related Terms
Innova Captab Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Innova Captab's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INNOVACAP vs ZTS, UTHR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Innova Captab's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innova Captab Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Innova Captab's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Innova Captab's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innova Captab (NSE:INNOVACAP) has a Pretax Margin % of 11.32% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Innova Captab and its competitors. This is near median its historical median of 11.53. Over the past decade, Innova Captab's Pretax Margin % has ranged from 9.73 to 13.85. According to the industry distribution chart, Innova Captab ranks #368 out of 961 companies in the Drug Manufacturers industry, placing it in the top 38.3%.
Is Innova Captab's Pretax Margin % too high?
Innova Captab's current Pretax Margin % of 11.32% is near median its 10-year median of 11.53. Over the past 10 years, this metric has ranged from a low of 9.73 to a high of 13.85. The Drug Manufacturers industry median Pretax Margin % is 7.28. Innova Captab's value of 11.32% is 55.5% above this industry median. Based on the distribution chart, Innova Captab ranks #368 out of 961 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Innova Captab has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Innova Captab's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Innova Captab ranks #368 out of 961 companies for Pretax Margin %. This puts Innova Captab in the upper half of its industry. The industry median Pretax Margin % is 7.28. Innova Captab's value of 11.32% is 55.5% above this benchmark. Historically, Innova Captab's own Pretax Margin % has ranged from 9.73 to 13.85 over the past decade. While the company's 10-year median is 11.53 vs. the industry median of 7.28, Innova Captab has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innova Captab's current Pretax Margin % of 11.32% is 55.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Innova Captab and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innova Captab's current Pretax Margin % is 11.32%, which is near median its own 10-year median of 11.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innova Captab stock overvalued right now?
Innova Captab (NSE:INNOVACAP) has a current Pretax Margin % of 11.32%. The current Pretax Margin % is 11.32%, which is near median its 10-year median of 11.53 and 55.5% above the Drug Manufacturers industry median of 7.28. Innova Captab's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Innova Captab (NSE:INNOVACAP), the current Pretax Margin % is 11.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Innova Captab Ltd is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company has identified "Drugs and pharmaceutical products" as single operating segment. The company has presence in India, and Outside India. The company generates majority of revenue from India. The company's products are Cephalosporins, Proton Pump Inhibitor, Antocholinergic and Heparin NSAIDs, Analgesics and Antipyretic, Anticold and Antiallergic, Antiemetic, Antidiabetic, Antispasmodic, Antifibrinolytic, Cardiovascular, Antioxidant and Vitamins, Antihyperuricemia and Antigout, Fluoroquinolone and Macrolide, Nootropics and Neurotonics/ Neurotrophics, Antiulcerative, Antimalarial Anxiolytic, Anticonvulsant and Antipsychotic, Bladder and Prostate Disorder, etc.
46GF Score
Get the complete analysis for NSE:INNOVACAP
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INNOVACAP has been successfully added to your 
